[
  {
    "ts": null,
    "headline": "Top 15 High-Growth Dividend Stocks For July 2025",
    "summary": "The Top 15 High-Growth Dividend Stocks for July 2025 boast a 1.38% yield, 18.78% growth rate and 23% undervaluation. Read more analysis here.",
    "url": "https://finnhub.io/api/news?id=db68923c43750f711ee4eb0686c20e0ef46577dda3b952452564eada3f9f2da7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751403721,
      "headline": "Top 15 High-Growth Dividend Stocks For July 2025",
      "id": 135700685,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2160360708/image_2160360708.jpg?io=getty-c-w1536",
      "related": "WRB",
      "source": "SeekingAlpha",
      "summary": "The Top 15 High-Growth Dividend Stocks for July 2025 boast a 1.38% yield, 18.78% growth rate and 23% undervaluation. Read more analysis here.",
      "url": "https://finnhub.io/api/news?id=db68923c43750f711ee4eb0686c20e0ef46577dda3b952452564eada3f9f2da7"
    }
  },
  {
    "ts": null,
    "headline": "Syntis Bio Closes $38 Million Financing to Accelerate Oral Therapies for Obesity and Rare Diseases",
    "summary": "BOSTON, July 01, 2025--Syntis Bio, Inc. (Syntis), a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes and rare diseases, announced today the close of a $33 million oversubscribed Series A financing. Cerberus Ventures led the round, with participation from new investors Mansueto Investments, Woori Venture Partners and Apollo Labs. Founding investors BOLD Capital Partners, W. R. Berkley Corporation, Safar Partners, Portal Innovations, Colorcon Ventures a",
    "url": "https://finnhub.io/api/news?id=7649f71f96111a4d380fc86fc185e71f7f1a764959a1dec5d6b3754ca398f577",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751374800,
      "headline": "Syntis Bio Closes $38 Million Financing to Accelerate Oral Therapies for Obesity and Rare Diseases",
      "id": 135694646,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WRB",
      "source": "Yahoo",
      "summary": "BOSTON, July 01, 2025--Syntis Bio, Inc. (Syntis), a clinical-stage biopharmaceutical company revolutionizing oral therapies for obesity, diabetes and rare diseases, announced today the close of a $33 million oversubscribed Series A financing. Cerberus Ventures led the round, with participation from new investors Mansueto Investments, Woori Venture Partners and Apollo Labs. Founding investors BOLD Capital Partners, W. R. Berkley Corporation, Safar Partners, Portal Innovations, Colorcon Ventures a",
      "url": "https://finnhub.io/api/news?id=7649f71f96111a4d380fc86fc185e71f7f1a764959a1dec5d6b3754ca398f577"
    }
  },
  {
    "ts": null,
    "headline": "Here's What to Expect From W. R. Berkley's Next Earnings Report",
    "summary": "W. R. Berkley is expected to release its fiscal second-quarter earnings later this month, and analysts project earnings to be in-line with the year-ago quarter.",
    "url": "https://finnhub.io/api/news?id=f97aeec9e70553d34b32f29d98ba5069f74ac7ae215801ccd955d7596a5a586e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751370229,
      "headline": "Here's What to Expect From W. R. Berkley's Next Earnings Report",
      "id": 135694647,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "WRB",
      "source": "Yahoo",
      "summary": "W. R. Berkley is expected to release its fiscal second-quarter earnings later this month, and analysts project earnings to be in-line with the year-ago quarter.",
      "url": "https://finnhub.io/api/news?id=f97aeec9e70553d34b32f29d98ba5069f74ac7ae215801ccd955d7596a5a586e"
    }
  },
  {
    "ts": null,
    "headline": "Berkley’s move towards strategic flexibility",
    "summary": "At the annual meeting of stockholders held on June 11, 2025, the Board of Directors of W. R. Berkley Corporation passed a resolution approving an increase in the authorized number of shares of common...",
    "url": "https://finnhub.io/api/news?id=4bd3ba5bdbdf7592a68fa956bbf8d1572848e16fbe9cea3a2719dd9cc70e84bb",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751344201,
      "headline": "Berkley’s move towards strategic flexibility",
      "id": 135684953,
      "image": "",
      "related": "WRB",
      "source": "Finnhub",
      "summary": "At the annual meeting of stockholders held on June 11, 2025, the Board of Directors of W. R. Berkley Corporation passed a resolution approving an increase in the authorized number of shares of common...",
      "url": "https://finnhub.io/api/news?id=4bd3ba5bdbdf7592a68fa956bbf8d1572848e16fbe9cea3a2719dd9cc70e84bb"
    }
  }
]